Cycloastragenol suppresses LPS-induced macrophage inflammation and promotes M2 polarization via TLR4/NF-κB signaling and SIRT1-related regulation.
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE Astragalus has long been used in traditional Chinese medicine for tonifying qi and supporting defensive functions. Cycloastragenol (CAG), a characteristic triterpenoid aglycone derived from Astragalus saponins, has emerging pharmacological relevance in immune and inflammatory regulation, but its role in macrophage inflammatory regulation and phenotypic remodeling remains insufficiently defined.
Aim
OF THE STUDY To investigate the effects of CAG on lipopolysaccharide (LPS)-induced macrophage inflammation and phenotypic remodeling, focusing on Toll-like receptor 4 (TLR4)/nuclear factor-κB (NF-κB) signaling and the involvement of sirtuin 1 (SIRT1).
Materials And Methods
RAW 264.7 macrophages were pretreated with CAG before LPS stimulation. Cytokine secretion, phenotype markers, and inflammatory signaling were evaluated by ELISA, immunofluorescence, reverse transcription quantitative PCR, and Western blotting. SIRT1-targeting small interfering RNA was used for functional evaluation. Network pharmacology prioritized candidate targets, while two acute inflammatory tissue transcriptomes and a normal human immune atlas provided expression context. Molecular docking and molecular dynamics simulations explored candidate CAG-protein interactions.
Results
Compared with LPS alone, CAG at 20 μmol/L reduced TNF-α from 56.15 ± 2.17 to 25.80 ± 1.87 pg/mL and IL-1β from 93.55 ± 2.66 to 44.49 ± 2.85 pg/mL (mean ± standard deviation; both Tukey-adjusted P < 0.0001). At this concentration, CAG decreased inducible nitric oxide synthase (iNOS) and CD86 and increased arginase-1 (ARG1) and CD206. Network pharmacology prioritized TLR4 and SIRT1. Wounded human skin and LPS-exposed mouse lungs showed increased expression of the gene encoding monocyte chemoattractant protein-1-induced protein 1 (MCPIP1). The human atlas detected transcripts for these regulators in macrophages and monocytes. CAG attenuated TLR4/NF-κB signaling and partially restored SIRT1 expression. During CAG treatment, SIRT1 silencing increased TLR4 expression, the phosphorylated/total p65 ratio, iNOS, and CD86 and decreased ARG1, weakening the signaling and phenotypic effects of CAG. Docking and simulations suggested possible CAG-protein interactions.
Conclusions
CAG attenuated LPS-induced macrophage inflammation and favored M2-associated phenotypic remodeling, with SIRT1 contributing to these effects. These findings support CAG as a promising Astragalus-derived immunomodulatory candidate and provide a basis for further exploration of its clinical translational potential.